TScan Therapeutics (TCRX) Revenue (2020 - 2026)
TScan Therapeutics (TCRX) reported Revenue of $586,000 for Q3 2026, down 76.7% from $2.51 million a year earlier and down 44.2% from the prior quarter.
TScan Therapeutics (TCRX) Revenue (2020 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, TScan Therapeutics' Revenue came in at $5.19 million, down 38.4% year-over-year; for FY2025, it came in at $10.33 million, up 266.7% from FY2024.
- Revenue has a five-year compound annual growth rate of 56.9% (FY2020 to FY2025).
- By year, Revenue came in at $2.82 million in FY2024 (-86.6%), $21.05 million in FY2023 (+55.5%), $13.54 million in FY2022 (+33.5%) and $10.14 million in FY2021 (+834.7%).
- The Q3 2026 figure ranks as the lowest quarterly Revenue since Q2 2024.
- Year over year, Revenue has now declined in each of the last three quarters, with growth averaging 111.8% over the last eight quarters.
- The high point for year-over-year Revenue in five years was Q2 2025 (growth of 473.9%); the low point was Q1 2024 (a decline of 91.7%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $1.05 million (Q2 2026), $982,000 (Q1 2026) and $2.57 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | 212,806.00 |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 24.40 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 25.40 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 17.40 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 18.09 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 10.37 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 8.30 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | TScan Therapeutics | 18.87 Mn | -434.83 Mn | - | 586,000.00 |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 586,000.00 |
| Jun 30, 2026 | 1.05 Mn |
| Mar 31, 2026 | 982,000.00 |
| Dec 31, 2025 | 2.57 Mn |
| Sep 30, 2025 | 2.51 Mn |
| Jun 30, 2025 | 3.08 Mn |
| Mar 31, 2025 | 2.17 Mn |
| Dec 31, 2024 | 665,000.00 |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 536,000.00 |
| Mar 31, 2024 | 566,000.00 |
| Dec 31, 2023 | 7.21 Mn |
| Sep 30, 2023 | 3.89 Mn |
| Jun 30, 2023 | 3.15 Mn |
| Mar 31, 2023 | 6.80 Mn |
| Dec 31, 2022 | 3.10 Mn |
| Sep 30, 2022 | 3.36 Mn |
| Jun 30, 2022 | 4.06 Mn |
| Mar 31, 2022 | 3.02 Mn |
| Dec 31, 2021 | 2.85 Mn |
TScan Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=TCRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "TCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=TCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();